Majocchi S, Lloveras P, Nouveau L, Legrand M, Viandier A, Malinge P, et al. NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control. Cancer Immunol Res. 2025;13:365-383 pubmed publisher

Xue X, Gajic Z, Caragine C, Legut M, Walker C, Kim J, et al. Paired CRISPR screens to map gene regulation in cis and trans. bioRxiv. 2024;: pubmed publisher

Shepelkova G, Evstifeev V, Berezovskiy Y, Ergeshova A, Tarasov R, Bagirov M, et al. Characteristics of Pulmonary Inflammation in Patients with Different Forms of Active Tuberculosis. Int J Mol Sci. 2024;25: pubmed publisher

Sedloev D, Chen Q, Unglaub J, Schanda N, Hao Y, Besiridou E, et al. Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. J Hematol Oncol. 2024;17:85 pubmed publisher

Malek E, Rana P, Swamydas M, Daunov M, Miyagi M, Murphy E, et al. The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nat Commun. 2024;15:7388 pubmed publisher

Jacobs M, Maas R, Jonkman I, Negishi Y, Tielemans Zamora W, Yanginlar C, et al. Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling. Cell Rep. 2024;43:114664 pubmed publisher

Pascual Pasto G, McIntyre B, Hines M, Giudice A, Garcia Gerique L, Hoffmann J, et al. CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma. Nat Commun. 2024;15:7141 pubmed publisher

Schiemann K, Belousova N, Matevossian A, Nallaparaju K, Kradjian G, Pandya M, et al. Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Mol Cancer Ther. 2024;23:1517-1529 pubmed publisher

Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X, et al. The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol Med. 2024;16:2080-2108 pubmed publisher

Gaifem J, Rodrigues C, Petralia F, Alves I, Leite Gomes E, Cavadas B, et al. A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan. Nat Immunol. 2024;25:1692-1703 pubmed publisher

Law C, Wacleche V, Cao Y, Pillai A, Sowerby J, Hancock B, et al. Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus. Nature. 2024;631:857-866 pubmed publisher

Jin Z, Hammoud H, Bhandage A, Korol S, Trujeque Ramos O, Koreli S, et al. GABA-mediated inhibition of human CD4+ T cell functions is enhanced by insulin but impaired by high glucose levels. EBioMedicine. 2024;105:105217 pubmed publisher

Mosquera Atehortua P, Figueira da Silva A, Mafra L, Almeida da Silveira S, de Mello C, Gomes Albuquerque H, et al. Clinical and parasitological features of Leishmania infection among gold miners in the Oiapoque basin, an international Brazil-French Guiana border. PLoS Negl Trop Dis. 2024;18:e0012210 pubmed publisher

Chen P, Chen Y, Chen H, Liao T, Chang S, Yeo K, et al. Association of the Reduced Levels of Monocyte Chemoattractant Protein-1 with Herpes Zoster in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors in a Single-Center Cohort. Microorganisms. 2024;12: pubmed publisher

Struckman N, de Jong R, Honders M, Smith S, van der Lee D, Koutsoumpli G, et al. Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for Immunotherapy. Biomedicines. 2024;12: pubmed publisher

Chen K, Sun W, Wu S, Feng P, Lin C, Chen T, et al. Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease. Cells. 2024;13: pubmed publisher

Cencioni M, Magliozzi R, Palmisano I, Suwan K, Mensi A, Fuentes Font L, et al. Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis. J Neuroinflammation. 2024;21:91 pubmed publisher

Bo x142 kun x, Starosz A, Kr x119 towska Grunwald A, Wasiluk T, Walewska A, Wierzbowska A, et al. Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients. Cancers (Basel). 2024;16: pubmed publisher

De M, Sukla S, Bharatiya S, Keshri S, Roy D, Roy S, et al. IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans. Infect Immun. 2024;92:e0050423 pubmed publisher

Wu W, Shiu C, Tong T, LEUNG S, Hui C. Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. J Immunol Res. 2023;2023:8924603 pubmed publisher

Jalilian E, Abolhasani Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci Rep. 2023;13:20770 pubmed publisher

Manna L, Rapuano Lembo R, Yoshioka A, Nakamura K, Passariello M, De Lorenzo C. A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies. Cancers (Basel). 2023;15: pubmed publisher

Rother N, Yanginlar C, Pr xe9 vot G, Jonkman I, Jacobs M, van Leent M, et al. Acid ceramidase regulates innate immune memory. Cell Rep. 2023;42:113458 pubmed publisher

Zobel C, Wenzel W, Kr xfc ger J, Baumgarten U, Wagel xf6 hner T, Neumann N, et al. Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression. Front Microbiol. 2023;14:1256210 pubmed publisher

Gysan M, Milacek C, Bal C, Zech A, Brugger J, Milos R, et al. Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial. PLoS ONE. 2023;18:e0293532 pubmed publisher

Dong B, Obermajer N, Tsuji T, Matsuzaki J, Bonura C, Withers H, et al. NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells. Res Sq. 2023;: pubmed publisher

Mellergaard M, Skovbakke S, Jepsen S, Panagiotopoulou N, Hansen A, Tian W, et al. Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor. MBio. 2023;14:e0134923 pubmed publisher

Baumer Y, Singh K, Baez A, Gutierrez Huerta C, Chen L, Igboko M, et al. Social Determinants modulate NK cell activity via obesity, LDL, and DUSP1 signaling. bioRxiv. 2023;: pubmed publisher

McCord B, Day R. Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation. Sci Rep. 2023;13:15935 pubmed publisher

Perales Linares R, Leli N, Mohei H, Beghi S, Rivera O, Kostopoulos N, et al. Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance. Cancer Res. 2023;83:3562-3576 pubmed publisher

Grubczak K, Starosz A, Makowska B, Parfienowicz Z, Kr x119 towska M, Naumnik B, et al. The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model. Sci Rep. 2023;13:12731 pubmed publisher

Ferreira A, Kostidis S, Groh L, Koeken V, Bruno M, Baydemir I, et al. Dimethyl itaconate induces long-term innate immune responses and confers protection against infection. Cell Rep. 2023;42:112658 pubmed publisher

Chang J, Chang S, Chen H, Chien Y, Yang H, Huang S, et al. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial. Brain Behav Immun. 2023;112:125-131 pubmed publisher

Sullivan K, Vilalta M, Ertl L, Wang Y, Dunlap C, Ebsworth K, et al. CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity. PLoS ONE. 2023;18:e0286724 pubmed publisher

Soliman R, Nishioka K, Daidoji T, Noyori O, Nakaya T. Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments. Biomedicines. 2023;11: pubmed publisher

Schmitz R, Tweed K, Rehani P, Samimi K, Riendeau J, Jones I, et al. Autofluorescence lifetime imaging classifies human lymphocyte activation and subtype. bioRxiv. 2023;: pubmed publisher

Asashima H, Mohanty S, Comi M, Ruff W, Hoehn K, Wong P, et al. PD-1highCXCR5-CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection. Cell Rep. 2023;42:111895 pubmed publisher

Teufel L, van der Made C, Kl xfc ck V, Simons A, Hoischen A, Vernimmen V, et al. Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study. Cytokine. 2023;162:156102 pubmed publisher

Eakin A, Ahmed T, McGeough C, Drain S, Alexander H, Wright G, et al. CD169+ Monocyte and Regulatory T Cell Subsets Are Associated with Disease Activity in Rheumatoid Arthritis. J Pers Med. 2022;12: pubmed publisher

Qiao J, Liu J, Jacobson J, Clark R, Lee S, Liu L, et al. Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma. PLoS ONE. 2022;17:e0277956 pubmed publisher

Wang Y, Zhao Y, Guo W, Yadav G, Bhaskarla C, Wang Z, et al. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Sci Adv. 2022;8:eadd0005 pubmed publisher

Heath J, Chour W, Choi J, Xie J, Chaffee M, Schmitt T, et al. Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Res Sq. 2022;: pubmed publisher

Reverchon F, Guillard C, Mollet L, Auzou P, Gosset D, Madouri F, et al. T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients. Biomedicines. 2022;10: pubmed publisher

Zhang Y, Zhuang Q, Wang F, Zhang C, Xu C, Gu A, et al. Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy. J Transl Med. 2022;20:432 pubmed publisher

Najimi M, Michel S, Binda M, Gellynck K, Belmonte N, Mazza G, et al. Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model. Cells. 2022;11: pubmed publisher

Yekehfallah V, Pahlavanneshan S, Sayadmanesh A, Momtahan Z, Ma B, Basiri M. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells. Biomolecules. 2022;12: pubmed publisher

Rossi F, Maldonado A, Cholewa J, Ribeiro S, de Ara xfa jo Barros C, Figueiredo C, et al. Exercise training-induced changes in immunometabolic markers in youth badminton athletes. Sci Rep. 2022;12:15539 pubmed publisher

Amormino C, Tedeschi V, Paldino G, Arcieri S, Fiorillo M, Paiardini A, et al. SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity. Cells. 2022;11: pubmed publisher

Berry S, Triplett O, Yu L, Hart M, Jackson L, Tolleson W. Microcalorimetric Investigations of Reversible Staphylococcal Enterotoxin Unfolding. Toxins (Basel). 2022;14: pubmed publisher

Hu J, Zhang Y, Yi S, Wang C, Huang X, Pan S, et al. Lithocholic acid inhibits dendritic cell activation by reducing intracellular glutathione via TGR5 signaling. Int J Biol Sci. 2022;18:4545-4559 pubmed publisher

Reljic D, Dieterich W, Herrmann H, Neurath M, Zopf Y. "HIIT the Inflammation": Comparative Effects of Low-Volume Interval Training and Resistance Exercises on Inflammatory Indices in Obese Metabolic Syndrome Patients Undergoing Caloric Restriction. Nutrients. 2022;14: pubmed publisher

Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, et al. Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D3. Cells. 2022;11: pubmed publisher

Jung B, Ferrer G, Chiu P, Aslam R, Ng A, Palacios F, et al. Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific manners. JCI Insight. 2022;7: pubmed publisher

Johanns S, Gantin R, Wangala B, Komlan K, Halatoko W, Banla M, et al. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo. PLoS Negl Trop Dis. 2022;16:e0010340 pubmed publisher

Passariello M, Yoshioka A, Takahashi K, Hashimoto S, Rapuano Lembo R, Manna L, et al. Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy. Int J Mol Sci. 2022;23: pubmed publisher

Hennings V, Th xf6 rn K, Albinsson S, Lingblom C, Andersson K, Andersson C, et al. The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19. Eur J Immunol. 2022;52:800-809 pubmed publisher

Gr xfc ner B, Peters L, Hillenbrand A, Vo xdf berg P, Schweiker J, Rollmann E, et al. Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up. PLoS Negl Trop Dis. 2022;16:e0010099 pubmed publisher

Weigand K, Peschel G, Grimm J, Luu K, Schacherer D, Wiest R, et al. Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology. Eur J Immunol. 2022;52:633-645 pubmed publisher

Romano M, Elgueta R, McCluskey D, Ortega Prieto A, Stolarczyk E, Dazzi F, et al. Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation In Vitro through Tryptophan Starvation. Cells. 2021;11: pubmed publisher

Vetrei C, Passariello M, Froechlich G, Rapuano Lembo R, Sasso E, Zambrano N, et al. Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC. Cancers (Basel). 2021;14: pubmed publisher

Holl J, Pawlukianiec C, Corton Ruiz J, Groth D, Grubczak K, Hady H, et al. Skin Substitute Preparation Method Induces Immunomodulatory Changes in Co-Incubated Cells through Collagen Modification. Pharmaceutics. 2021;13: pubmed publisher

Tosi A, Nardinocchi L, Carbone M, Capriotti L, Pagani E, Mastroeni S, et al. Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma. Biomedicines. 2021;9: pubmed publisher

Qiao Y, Qiu Y, Ding J, Luo N, Wang H, Ling X, et al. Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity. Nat Commun. 2021;12:6360 pubmed publisher

Yao N, Tretter T, Kvacskay P, Merkt W, Blank N, Lorenz H, et al. Targeting of Janus Kinases Limits Pro-Inflammatory but Also Immunosuppressive Circuits in the Crosstalk between Synovial Fibroblasts and Lymphocytes. Biomedicines. 2021;9: pubmed publisher

Xiao Y, Chen P, Luo C, Xu Z, Li X, Liu L, et al. Discovery of a novel anti PD-L1 X TIGIT bispecific antibody for the treatment of solid tumors. Cancer Treat Res Commun. 2021;29:100467 pubmed publisher

Fendler A, Au L, Shepherd S, Byrne F, Cerrone M, Boos L, et al. Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Res Sq. 2021;: pubmed publisher

Strijker J, Pscheid R, Drent E, van der Hoek J, Koopmans B, Ober K, et al. αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression. J Pers Med. 2021;11: pubmed publisher

Roig Carles D, Willms E, Fontijn R, Martinez Pacheco S, Mäger I, de Vries H, et al. Endothelial-Derived Extracellular Vesicles Induce Cerebrovascular Dysfunction in Inflammation. Pharmaceutics. 2021;13: pubmed publisher

Iannetta M, Landi D, Cola G, Malagnino V, Teti E, Fraboni D, et al. T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Mult Scler Relat Disord. 2021;55:103157 pubmed publisher

Katopodi T, Petanidis S, Domvri K, Zarogoulidis P, Anestakis D, Charalampidis C, et al. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit. Sci Rep. 2021;11:15455 pubmed publisher

Serrano R, Coch C, Peters C, Hartmann G, Wesch D, Kabelitz D. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands. Sci Rep. 2021;11:15231 pubmed publisher

Jamal Jameel K, Gallert W, Yanik S, Panek S, Kronsbein J, Jungck D, et al. Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD. Int J Mol Sci. 2021;22: pubmed publisher

Aschmoneit N, Steinlein S, Kühl L, Seifert O, Kontermann R. A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells. Sci Rep. 2021;11:13880 pubmed publisher

Martel A, Fraleigh N, Picard E, Lewicky J, Pawelec G, Lee H, et al. Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome. Int J Pharm. 2021;606:120849 pubmed publisher

Samarkanova D, Cox S, Hernandez D, Rodriguez L, Pérez M, Madrigal A, et al. Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties. Sci Rep. 2021;11:13754 pubmed publisher

Sun R, Zhou Y, Han L, Pan Z, Chen J, Zong H, et al. A Rational Designed Novel Bispecific Antibody for the Treatment of GBM. Biomedicines. 2021;9: pubmed publisher

Jover E, Matilla L, Garaikoetxea M, Fernández Celis A, Muntendam P, Jaisser F, et al. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines. 2021;9: pubmed publisher

Vetrei C, Passariello M, Froechlich G, Rapuano Lembo R, Zambrano N, De Lorenzo C. Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments. Cancers (Basel). 2021;13: pubmed publisher

Hu Y, Tsai I, Hsu H, Chiang B, Yang Y. Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-alpha production. Arthritis Res Ther. 2021;23:171 pubmed publisher

Rousso Noori L, Mastandrea I, Talmor S, Waks T, Globerson Levin A, Haugas M, et al. P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas. Nat Commun. 2021;12:3615 pubmed publisher

Mathiasen S, Gall Mas L, Pateras I, Theodorou S, Namini M, Hansen M, et al. Bacterial genotoxins induce T cell senescence. Cell Rep. 2021;35:109220 pubmed publisher

Costa F, Leite J, Rassi D, da Silva J, Elias Oliveira J, Guimar xe3 es J, et al. NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes. Cell Rep. 2021;35:109176 pubmed publisher

Renner K, Schwittay T, Chaabane S, Gottschling J, Muller C, Tiefenböck C, et al. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes. Nat Commun. 2021;12:3006 pubmed publisher

Dieterich W, Tietz E, Kohl M, Konturek P, Rath T, Neurath M, et al. Food Intolerance of Unknown Origin: Caused by Mucosal Inflammation? A Pilot Study. Clin Transl Gastroenterol. 2021;12:e00312 pubmed publisher

Roberts A, Bentley L, Tang T, Stewart F, Pallini C, Juvvanapudi J, et al. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation. Sci Rep. 2021;11:4030 pubmed publisher

Madeira R, Dal Mas Romera L, de Cássia Buck P, Mady C, Ianni B, Torrecilhas A. New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response. J Immunol Res. 2021;2021:6650670 pubmed publisher

Biswas S, Mittal M, Sinha E, Singh V, Arela N, Bajaj B, et al. Exploring the Role of C-C Motif Chemokine Ligand-2 Single Nucleotide Polymorphism in Pulmonary Tuberculosis: A Genetic Association Study from North India. J Immunol Res. 2020;2020:1019639 pubmed publisher

Taborska P, Stakheev D, Svobodová H, Strizova Z, Bartunkova J, Smrz D. Acute Conditioning of Antigen-Expanded CD8+ T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge. Cancers (Basel). 2020;12: pubmed publisher

Radujkovic A, Boch T, Nolte F, Nowak D, Kunz C, Gieffers A, et al. Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile. Cancers (Basel). 2020;12: pubmed publisher

De M, Bhushan A, Chinnaswamy S. Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes. J Leukoc Biol. 2020;: pubmed publisher

Lee H, Jeong G. Aromadendrin Inhibits T Cell Activation via Regulation of Calcium Influx and NFAT Activity. Molecules. 2020;25: pubmed publisher

Sainson R, Thotakura A, Kosmac M, Borhis G, Parveen N, Kimber R, et al. An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression. Cancer Immunol Res. 2020;8:1568-1582 pubmed publisher

Radujkovic A, Kordelas L, Bogdanov R, Muller Tidow C, Beelen D, Dreger P, et al. Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation. Cancers (Basel). 2020;12: pubmed publisher

Li L, Gao Y, Srivastava R, Wang W, Xiong Q, Fang Z, et al. Lentiviral delivery of combinatorial CAR/CRISPRi circuit into human primary T cells is enhanced by TBK1/IKKɛ complex inhibitor BX795. J Transl Med. 2020;18:363 pubmed publisher

Liu M, Wang X, Li W, Yu X, FLORES VILLANUEVA P, Xu Monette Z, et al. Targeting PD-L1 in non-small cell lung cancer using CAR T cells. Oncogenesis. 2020;9:72 pubmed publisher

Passariello M, Vetrei C, Sasso E, Froechlich G, Gentile C, D Alise A, et al. Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells. Cancers (Basel). 2020;12: pubmed publisher

Bibby J, Purvis H, Hayday T, Chandra A, Okkenhaug K, Rosenzweig S, et al. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat Commun. 2020;11:3412 pubmed publisher

Liu Y, Bockermann R, Hadi M, Safari I, Carrion B, Kveiborg M, et al. ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation. Cell Mol Immunol. 2020;: pubmed publisher

James R, Schalks R, Browne E, Eleftheriadou I, Munoz C, Mazarakis N, et al. Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration. Acta Neuropathol Commun. 2020;8:66 pubmed publisher

Jonescheit H, Oberg H, Gonnermann D, Hermes M, Sulaj V, Peters C, et al. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells. Cells. 2020;9: pubmed publisher

Herrera M, Vera C, Keynan Y, Rueda Z. Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review. J Immunol Res. 2020;2020:8074183 pubmed publisher

Elemam N, Hachim M, Hannawi S, Maghazachi A. Differentially Expressed Genes of Natural Killer Cells Can Distinguish Rheumatoid Arthritis Patients from Healthy Controls. Genes (Basel). 2020;11: pubmed publisher

Kopecka J, Godel M, Dei S, Giampietro R, Belisario D, Akman M, et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells. 2020;9: pubmed publisher

Lee J, Shklovskaya E, Lim S, Carlino M, Menzies A, Stewart A, et al. Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. Nat Commun. 2020;11:1897 pubmed publisher

Huetter J, Gritzan U, Gutcher I, Doecke W, Luetke Eversloh M, Golfier S, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunol Res. 2020;8:895-911 pubmed publisher

Roh H, Cho S, So W. A Cross-Sectional Study Evaluating the Effects of Resistance Exercise on Inflammation and Neurotrophic Factors in Elderly Women with Obesity. J Clin Med. 2020;9: pubmed publisher

Serrano R, Wesch D, Kabelitz D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells. 2020;9: pubmed publisher

Di Pace A, Tumino N, Besi F, Alicata C, Conti L, Munari E, et al. Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against Tumor. Cancers (Basel). 2020;12: pubmed publisher

Guedan S, Madar A, Casado Medrano V, Shaw C, Wing A, Liu F, et al. Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability. J Clin Invest. 2020;130:3087-3097 pubmed publisher

Hernández Castañeda M, Happ K, Cattalani F, Wallimann A, Blanchard M, Fellay I, et al. γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage. J Immunol. 2020;204:1798-1809 pubmed publisher

Passariello M, Camorani S, Vetrei C, Ricci S, Cerchia L, De Lorenzo C. Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. Cancers (Basel). 2020;12: pubmed publisher

Gardizani T, Della Coletta A, Romagnoli G, Puccia R, Serezani A, de Campos Soares A, et al. 43 kDa Glycoprotein (gp43) from Paracoccidioides brasiliensis Induced IL-17A and PGE2 Production by Human Polymorphonuclear Neutrophils: Involvement of TLR2 and TLR4. J Immunol Res. 2019;2019:1790908 pubmed publisher

Carpenter R, Jiang R, Brennan F, Hall J, Gottipati M, Niewiesk S, et al. Human immune cells infiltrate the spinal cord and impair recovery after spinal cord injury in humanized mice. Sci Rep. 2019;9:19105 pubmed publisher

Qi J, Du L, Deng J, Qin Y, Su G, Hou S, et al. Replication of Genome-Wide Association Analysis Identifies New Susceptibility Loci at Long Noncoding RNA Regions for Vogt-Koyanagi-Harada Disease. Invest Ophthalmol Vis Sci. 2019;60:4820-4829 pubmed publisher

Kim S, Jang J, Koh J, Kwon D, Kim Y, Paeng J, et al. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer. J Exp Clin Cancer Res. 2019;38:462 pubmed publisher

Renner K, Bruss C, Schnell A, Koehl G, Becker H, Fante M, et al. Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy. Cell Rep. 2019;29:135-150.e9 pubmed publisher

Ahn H, Kim S, Kwon D, Koh J, Kim Y, Kim K, et al. MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function. Int J Mol Sci. 2019;20: pubmed publisher

Dimou P, Wright R, Budge K, Midgley A, Satchell S, Peak M, et al. The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis. Sci Rep. 2019;9:8348 pubmed publisher

Sasikumar P, Ramachandra R, Adurthi S, Dhudashiya A, Vadlamani S, Vemula K, et al. A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy. Mol Cancer Ther. 2019;18:1081-1091 pubmed publisher

Su L, Pan P, Yan P, Long Y, Zhou X, Wang X, et al. Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Sci Rep. 2019;9:5747 pubmed publisher

Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64 pubmed publisher

Gramlich R, Aliahmadi E, Peiser M. In Vitro Induction of T Helper 17 Cells by Synergistic Activation of Human Monocyte-Derived Langerhans Cell-Like Cells with Bacterial Agonists. Int J Mol Sci. 2019;20: pubmed publisher

Islam A, Urbarova I, Bruun J, Martínez Zubiaurre I. Large-scale secretome analyses unveil the superior immunosuppressive phenotype of umbilical cord stromal cells as compared to other adult mesenchymal stromal cells. Eur Cell Mater. 2019;37:153-174 pubmed publisher

Klapdor R, Wang S, Morgan M, Dork T, Hacker U, Hillemanns P, et al. Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer. Int J Mol Sci. 2019;20: pubmed publisher

Masu T, Atsukawa M, Nakatsuka K, Shimizu M, Miura D, Arai T, et al. Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression. PLoS ONE. 2018;13:e0200664 pubmed publisher

Lopatina T, Favaro E, Grange C, Cedrino M, Ranghino A, Occhipinti S, et al. PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia. Sci Rep. 2018;8:17458 pubmed publisher

Idowu A, Bhattacharyya S, Gradus S, Oyibo W, George Z, Black C, et al. Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction. Int J Med Sci. 2018;15:1449-1457 pubmed publisher

Sheth C, López Pedrajas R, Jovani Sancho M, González Martínez R, Veses V. Modulation of salivary cytokines in response to alcohol, tobacco and caffeine consumption: a pilot study. Sci Rep. 2018;8:16687 pubmed publisher

Al Dali A, Weiher H, Schmidt Wolf I. Utilizing ethacrynic acid and ciclopirox olamine in liver cancer. Oncol Lett. 2018;16:6854-6860 pubmed publisher

Yi S, Chang R, Hu J, Qiu Y, Wang Q, Cao Q, et al. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease. Invest Ophthalmol Vis Sci. 2018;59:4662-4669 pubmed publisher

Strzadala L, Fiedorowicz A, Wysokińska E, Ziolo E, Grudzień M, Jelen M, et al. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Molecules. 2018;23: pubmed publisher

Pandey R, Bakay M, Hain H, Strenkowski B, Elsaqa B, Roizen J, et al. CLEC16A regulates splenocyte and NK cell function in part through MEK signaling. PLoS ONE. 2018;13:e0203952 pubmed publisher

Laustsen A, Bak R, Krapp C, Kjær L, Egedahl J, Petersen C, et al. Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function. Nat Commun. 2018;9:3525 pubmed publisher

Vahedi F, Lee A, Collins S, Chew M, Lusty E, Chen B, et al. IL-15 and IFN-? signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling. Cytokine. 2018;: pubmed publisher

Marre M, McGinty J, Chow I, DeNicola M, Beck N, Kent S, et al. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes. Diabetes. 2018;67:1356-1368 pubmed publisher

Hagan S, Fyfe M, Ofori Frimpong B, Oliver K, Foster M, Sirohi S, et al. Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. Invest Ophthalmol Vis Sci. 2018;59:1443-1453 pubmed publisher

Wing A, Fajardo C, Posey A, Shaw C, Da T, Young R, et al. Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager. Cancer Immunol Res. 2018;6:605-616 pubmed publisher

Zhang D, Qin J, Li L, Su G, Huang G, Cao Q, et al. Analysis of the association between Fc receptor family gene polymorphisms and ocular Behçet's disease in Han Chinese. Sci Rep. 2018;8:4850 pubmed publisher

Huang F, Wang B, Zeng J, Sang S, Lei J, Lu Y. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells. Oncol Lett. 2018;15:4797-4804 pubmed publisher

Emami Shahri N, Foster J, Kashani R, Gazinska P, Cook C, Sosabowski J, et al. Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells. Nat Commun. 2018;9:1081 pubmed publisher

Yue Y, Zhang J, Yang L, Liu S, Qi J, Cao Q, et al. Association of Long Noncoding RNAs Polymorphisms With Ankylosing Spondylitis, Vogt-Koyanagi-Harada Disease, and Behcet's Disease. Invest Ophthalmol Vis Sci. 2018;59:1158-1166 pubmed publisher

Clarke A, Poulton L, Shim D, Mabon D, Butt D, Pollard M, et al. An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease. MAbs. 2018;10:664-677 pubmed publisher

Batt J, Milward M, Chapple I, Grant M, Roberts H, Addison O. TiO2 nanoparticles can selectively bind CXCL8 impacting on neutrophil chemotaxis. Eur Cell Mater. 2018;35:13-24 pubmed publisher

Galland S, Vuille J, Martin P, Letovanec I, Caignard A, Fregni G, et al. Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets. Cell Rep. 2017;20:2891-2905 pubmed publisher

Lusty E, Poznanski S, Kwofie K, Mandur T, Lee D, Richards C, et al. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-? production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. Mol Immunol. 2017;88:138-147 pubmed publisher

Fujii K, Miyahara Y, Harada N, Muraoka D, Komura M, Yamaguchi R, et al. Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors. Oncoimmunology. 2017;6:e1306617 pubmed publisher

Souza M, Fonseca D, Kanashiro A, Benevides L, Medina T, Dias M, et al. Chronic Toxoplasma gondii Infection Exacerbates Secondary Polymicrobial Sepsis. Front Cell Infect Microbiol. 2017;7:116 pubmed publisher

Strassner J, Rashighi M, Ahmed Refat M, Richmond J, Harris J. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 2017;76:847-855.e5 pubmed publisher

Kathamuthu G, Moideen K, Baskaran D, Banurekha V, Nair D, Sekar G, et al. Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1? (IL-1?) and IL-18 at the Site of Infection. Clin Vaccine Immunol. 2017;24: pubmed publisher

Hojo Souza N, Pereira D, de Souza F, de Oliveira Mendes T, Cardoso M, Tada M, et al. On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease. Malar J. 2017;16:42 pubmed publisher

Onkoba N, Chimbari M, Kamau J, Mukaratirwa S. Metabolic and adaptive immune responses induced in mice infected with tissue-dwelling nematode Trichinella zimbabwensis. Open Vet J. 2016;6:178-184 pubmed

Kathamuthu G, Moideen K, Bhaskaran D, Sekar G, Sridhar R, Vidyajayanthi B, et al. Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis. Cytokine. 2017;90:66-72 pubmed publisher

Hashimoto S, Yamamoto S, Ogasawara N, Sato T, Yamamoto K, Katoh H, et al. Mumps Virus Induces Protein-Kinase-R-Dependent Stress Granules, Partly Suppressing Type III Interferon Production. PLoS ONE. 2016;11:e0161793 pubmed publisher

Mattana A, Sanna M, Cano A, Delogu G, Erre G, Roberts C, et al. Acanthamoeba castellanii Genotype T4 Stimulates the Production of Interleukin-10 as Well as Proinflammatory Cytokines in THP-1 Cells, Human Peripheral Blood Mononuclear Cells, and Human Monocyte-Derived Macrophages. Infect Immun. 2016;84:2953-62 pubmed publisher

Dias A, Silva C, Santos J, Batista Silva L, Acosta C, Fontes A, et al. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum. J Immunol. 2016;197:1905-13 pubmed publisher

Talreja J, Talwar H, Ahmad N, Rastogi R, Samavati L. Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1? and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells. J Immunol. 2016;197:1368-78 pubmed publisher

Yoo J, Jaime Ramirez A, Bolyard C, Dai H, Nallanagulagari T, Wojton J, et al. Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. Clin Cancer Res. 2016;22:5265-5276 pubmed

Qin J, Li L, Zhang D, Yu H, Tan H, Zhang J, et al. Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease. Sci Rep. 2016;6:26662 pubmed publisher

Iizuka Y, Cichocki F, Sieben A, Sforza F, Karim R, Coughlin K, et al. UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion. J Immunol. 2015;195:4760-70 pubmed publisher

Mattiola I, Pesant M, Tentorio P, Molgora M, Marcenaro E, Lugli E, et al. Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways. J Immunol. 2015;195:2818-28 pubmed publisher

Jiang Z, Hennein L, Tao Y, Tao L. Interleukin-23 Receptor Gene Polymorphism May Enhance Expression of the IL-23 Receptor, IL-17, TNF-α and IL-6 in Behcet's Disease. PLoS ONE. 2015;10:e0134632 pubmed publisher

Campia I, Buondonno I, Castella B, Rolando B, Kopecka J, Gazzano E, et al. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells. PLoS ONE. 2015;10:e0126159 pubmed publisher

Wu M, Zhang T, Gacerez A, Coupet T, Demars L, Sentman C. B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity. J Immunol. 2015;194:5305-11 pubmed publisher

Wu M, Zhang T, DeMars L, Sentman C. B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity. Gene Ther. 2015;22:675-84 pubmed publisher

Guirado E, Mbawuike U, Keiser T, Arcos J, Azad A, Wang S, et al. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. MBio. 2015;6:e02537-14 pubmed publisher

Hojo Souza N, Pereira D, Passos L, Gazzinelli Guimarães P, Cardoso M, Tada M, et al. Phenotypic profiling of CD8(+) T cells during Plasmodium vivax blood-stage infection. BMC Infect Dis. 2015;15:35 pubmed publisher

Rodrigues D, Fernandes R, Balderramas H, Penitenti M, Bachiega T, Calvi S, et al. Interferon-gamma production by human neutrophils upon stimulation by IL-12, IL-15 and IL-18 and challenge with Paracoccidioides brasiliensis. Cytokine. 2014;69:102-9 pubmed publisher

Tsukahara T, Emori M, Murata K, Hirano T, Muroi N, Kyono M, et al. Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody. J Biol Chem. 2014;289:22035-47 pubmed publisher

Liukko A, Kinnunen T, Rytkönen Nissinen M, Kailaanmäki A, Randell J, Maillere B, et al. Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other. PLoS ONE. 2014;9:e98461 pubmed publisher

Zhang Q, Qi J, Hou S, Du L, Yu H, Cao Q, et al. A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis. PLoS ONE. 2014;9:e96943 pubmed publisher

Assani K, Tazi M, Amer A, Kopp B. IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. PLoS ONE. 2014;9:e96681 pubmed publisher

Sun M, Yang P, Du L, Yang Y, Ye J. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease. PLoS ONE. 2014;9:e93214 pubmed publisher

Kis Toth K, Tsokos G. Engagement of SLAMF2/CD48 prolongs the time frame of effective T cell activation by supporting mature dendritic cell survival. J Immunol. 2014;192:4436-42 pubmed publisher

Wang R, Sun P. Natural killer cell-mediated shedding of ULBP2. PLoS ONE. 2014;9:e91133 pubmed publisher

Arndts K, Specht S, Debrah A, Tamarozzi F, Klarmann Schulz U, Mand S, et al. Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels. PLoS Negl Trop Dis. 2014;8:e2679 pubmed publisher

Prigent L, Robineau M, Jouneau S, Morzadec C, Louarn L, Vernhet L, et al. The aryl hydrocarbon receptor is functionally upregulated early in the course of human T-cell activation. Eur J Immunol. 2014;44:1330-40 pubmed publisher

Evans H, Roostalu U, Walter G, Gullick N, Frederiksen K, Roberts C, et al. TNF-? blockade induces IL-10 expression in human CD4+ T cells. Nat Commun. 2014;5:3199 pubmed publisher

Harfuddin Z, Kwajah S, Chong Nyi Sim A, MacAry P, Schwarz H. CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses. Oncoimmunology. 2013;2:e26859 pubmed

Cheng K, Wong S, Linn Y, Ho L, Chng W, Schwarz H. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells. Br J Haematol. 2014;165:134-44 pubmed publisher

Seeger P, Bosisio D, Parolini S, Badolato R, Gismondi A, Santoni A, et al. Activin A as a mediator of NK-dendritic cell functional interactions. J Immunol. 2014;192:1241-8 pubmed publisher

Yu F, Wang X, Guo Z, Bartlett D, Gottschalk S, Song X. T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy. Mol Ther. 2014;22:102-11 pubmed publisher

Justiniano S, Elavazhagan S, Fatehchand K, Shah P, Mehta P, Roda J, et al. Fc? receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem. 2013;288:26800-9 pubmed publisher

Slavica L, Nordström I, Karlsson M, Valadi H, Kacerovsky M, Jacobsson B, et al. TLR3 impairment in human newborns. J Leukoc Biol. 2013;94:1003-11 pubmed publisher

Arndts K, Deininger S, Specht S, Klarmann U, Mand S, Adjobimey T, et al. Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis. 2012;6:e1611 pubmed publisher

van de Veerdonk F, Stoeckman A, Wu G, Boeckermann A, Azam T, Netea M, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A. 2012;109:3001-5 pubmed publisher

Wang R, Jaw J, Stutzman N, Zou Z, Sun P. Natural killer cell-produced IFN-? and TNF-? induce target cell cytolysis through up-regulation of ICAM-1. J Leukoc Biol. 2012;91:299-309 pubmed publisher

Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, et al. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2011;52:7084-9 pubmed publisher

Jiang S, Liu X, Luo L, Qu B, Huang X, Lin Y, et al. Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol Vis. 2011;17:1425-30 pubmed

Barber A, Sentman C. NKG2D receptor regulates human effector T-cell cytokine production. Blood. 2011;117:6571-81 pubmed publisher

Perier A, Fregni G, Wittnebel S, Gad S, Allard M, Gervois N, et al. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Oncogene. 2011;30:2622-32 pubmed publisher

Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, et al. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol. 2010;184:4880-8 pubmed publisher

Xu D, Lin L, Lin X, Huang Z, Lei Z. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown. Cell Immunol. 2010;263:71-8 pubmed publisher

Campbell J, Edwards K, Ring C, Drayson M, Bosch J, Inskip A, et al. The effects of vaccine timing on the efficacy of an acute eccentric exercise intervention on the immune response to an influenza vaccine in young adults. Brain Behav Immun. 2010;24:236-42 pubmed publisher

Christophi G, Panos M, Hudson C, Tsikkou C, Mihai C, Mejico L, et al. Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clin Immunol. 2009;133:27-44 pubmed publisher

Aliahmadi E, Gramlich R, Grützkau A, Hitzler M, Krüger M, Baumgrass R, et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur J Immunol. 2009;39:1221-30 pubmed publisher

Eid R, Rao D, Zhou J, Lo S, Ranjbaran H, Gallo A, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119:1424-32 pubmed publisher

Cerboni C, Ardolino M, Santoni A, Zingoni A. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. Blood. 2009;113:2955-64 pubmed publisher

Maneechotesuwan K, Wamanuttajinda V, Kasetsinsombat K, Huabprasert S, Yaikwawong M, Barnes P, et al. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. J Allergy Clin Immunol. 2009;123:239-48 pubmed publisher

Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol. 2008;64:187-99 pubmed publisher

Novitskiy S, Ryzhov S, Zaynagetdinov R, Goldstein A, Huang Y, Tikhomirov O, et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood. 2008;112:1822-31 pubmed publisher

Gendron S, Boisvert M, Chetoui N, Aoudjit F. Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function. Immunology. 2008;125:359-69 pubmed publisher

Lamhamedi Cherradi S, Martin R, Ito T, Kheradmand F, CORRY D, Liu Y, et al. Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol. 2008;180:6000-9 pubmed

Chen L, Yang P, Zhou H, He H, Ren X, Chi W, et al. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008;49:3475-82 pubmed publisher

Wu B, Huang C, Kato Maeda M, Hopewell P, Daley C, Krensky A, et al. IL-24 modulates IFN-gamma expression in patients with tuberculosis. Immunol Lett. 2008;117:57-62 pubmed publisher

Matalka K, Ali D, Khawad A, Qa dan F. The differential effect of Eriobotrya japonica hydrophilic leaf extract on cytokines production and modulation. Cytokine. 2007;40:235-40 pubmed

Nassenstein C, Kammertoens T, Veres T, Uckert W, Spies E, Fuchs B, et al. Neuroimmune crosstalk in asthma: dual role of the neurotrophin receptor p75NTR. J Allergy Clin Immunol. 2007;120:1089-96 pubmed

Barber A, Zhang T, Demars L, Conejo Garcia J, Roby K, Sentman C. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer. Cancer Res. 2007;67:5003-8 pubmed

Lauzon N, Mian F, MacKenzie R, Ashkar A. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol. 2006;241:102-12 pubmed

Cho Y, Ahn B, Lee N, Lee D, Kim D. A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy. Vaccine. 2006;24:5862-71 pubmed

Cox A, Coles A, Nortje J, Bradley P, Chatfield D, Thompson S, et al. An investigation of auto-reactivity after head injury. J Neuroimmunol. 2006;174:180-6 pubmed

Miranda Carús M, Balsa A, Benito Miguel M, Pérez de Ayala C, Martin Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol. 2004;173:1463-76 pubmed

de Jesus A, Magalhaes A, Miranda D, Miranda R, Araujo M, de Jesus A, et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun. 2004;72:3391-7 pubmed

Weigt H, Muhlradt P, Larbig M, Krug N, Braun A. The Toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model. J Immunol. 2004;172:6080-6 pubmed

Misra A, Dube A, Naik S. Immune responses in normal Indian langur monkeys (Presbytis entellus)--a primate model for visceral leishmaniasis. J Med Primatol. 2004;33:65-9 pubmed

Finney H, Akbar A, Lawson A. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain. J Immunol. 2004;172:104-13 pubmed

Groh V, Bruhl A, El Gabalawy H, Nelson J, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2003;100:9452-7 pubmed

Channon J, Miselis K, Minns L, Dutta C, Kasper L. Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis. Infect Immun. 2002;70:6048-57 pubmed